cicletanine has been researched along with iloprost in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Emden, J; Mironneau, J; Siegel, G; Stock, G; Wenzel, K | 1 |
| Buddecke, E; Loirand, G; Schmidt, A; Schnalke, F; Siegel, G; Stock, G; Walter, A | 1 |
| Ewert, R; Felix, S; Opitz, C; Schlag, K; Wensel, R | 1 |
3 other study(ies) available for cicletanine and iloprost
| Article | Year |
|---|---|
Potassium channel activation in vascular smooth muscle.
Topics: Animals; Antihypertensive Agents; Basilar Artery; Carotid Arteries; Coronary Vessels; Diuretics; Dogs; Endothelium, Vascular; Iloprost; In Vitro Techniques; Indomethacin; Membrane Potentials; Muscle Contraction; Muscle, Smooth, Vascular; Oxidopamine; Portal Vein; Potassium Channels; Pyridines; Rabbits; Rats; Rats, Inbred Strains; Vasodilation | 1992 |
Potassium channel activation, hyperpolarization, and vascular relaxation.
Topics: Animals; Antihypertensive Agents; Calcium; Culture Techniques; Diuretics; Dogs; Endothelium, Vascular; GTP-Binding Proteins; Iloprost; Magnetic Resonance Spectroscopy; Membrane Potentials; Muscle, Smooth, Vascular; Norepinephrine; Oxygen Consumption; Potassium Channels; Pyridines; Rabbits; Rats; Rats, Inbred Strains; Second Messenger Systems; Sodium Channels; Vasodilation | 1991 |
[Pulmonary hypertension in hereditary haemorrhagic teleangiectasia (Rendu-Osler-Weber disease). Progression over 10 years].
Topics: Anticoagulants; Antihypertensive Agents; Bosentan; Calcium Channel Blockers; Diuretics; Endothelin Receptor Antagonists; Epistaxis; Epoprostenol; Female; Furosemide; Humans; Hypertension, Pulmonary; Iloprost; Middle Aged; Nifedipine; Pedigree; Phenprocoumon; Pyridines; Sulfonamides; Telangiectasia, Hereditary Hemorrhagic; Treatment Failure; Vasodilator Agents | 2005 |